Gaudium IVF and Women Health Limited (NSE:GAUDIUMIVF)
80.97
+0.10 (0.12%)
At close: Mar 13, 2026
NSE:GAUDIUMIVF Revenue
In the fiscal year ending March 31, 2025, Gaudium IVF and Women Health had annual revenue of 707.24M INR with 47.68% growth. Gaudium IVF and Women Health had revenue of 195.16M in the quarter ending March 31, 2025.
Revenue
707.24M
Revenue Growth
+47.68%
P/S Ratio
8.33
Revenue / Employee
6.04M
Employees
117
Market Cap
5.89B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 707.24M | 228.34M | 47.68% |
| Mar 31, 2024 | 478.90M | 36.35M | 8.21% |
| Mar 31, 2023 | 442.55M | 77.36M | 21.18% |
| Mar 31, 2022 | 365.20M | 303.45M | 491.39% |
| Mar 31, 2021 | 61.75M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Magadh Sugar & Energy | 13.09B |
| Elin Electronics | 12.79B |
| United Polyfab Gujarat | 6.60B |
| Snowman Logistics | 5.99B |
| Australian Premium Solar (India) | 5.72B |
| Indo Farm Equipment | 4.36B |
| Sejal Glass | 3.50B |
| South West Pinnacle Exploration | 2.40B |